HansBiomed Corporation reported earnings results for the first quarter ended December 31, 2023. For the first quarter, the company reported sales was KRW 884.29 million compared to KRW 891.42 million a year ago. Net loss was KRW 1,022.71 million compared to KRW 3,587.86 million a year ago.

Basic loss per share from continuing operations was KRW 79 compared to KRW 374 a year ago. Basic loss per share was KRW 79 compared to KRW 374 a year ago.